Abstract
Assessing the mid-term impact of enhanced prostate cancer screening in Caucasian men with germline DNA repair pathogenic variants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1200/jco.2024.42.4_suppl.278
Copy DOIJournal: Journal of Clinical Oncology | Publication Date: Feb 1, 2024 |
Assessing the mid-term impact of enhanced prostate cancer screening in Caucasian men with germline DNA repair pathogenic variants.
Join us for a 30 min session where you can share your feedback and ask us any queries you have